Found: 23
Select item for more details and to access through your institution.
Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease Patients.
- Published in:
- Frontiers in Neurology, 2018, p. N.PAG, doi. 10.3389/fneur.2018.00645
- By:
- Publication type:
- Article
Impact of Oral Fast Release Amantadine on Movement Performance in Patients with Parkinson's Disease.
- Published in:
- Pharmaceutics, 2010, v. 2, n. 3, p. 313, doi. 10.3390/pharmaceutics2030313
- By:
- Publication type:
- Article
Coronal Transcranial Sonography and M-Mode Tremor Frequency Determination in Parkinson's Disease and Essential Tremor.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Parkinson's Disease Multimodal Complex Treatment (PD-MCT): Analysis of Therapeutic Effects and Predictors for Improvement.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1874, doi. 10.3390/jcm9061874
- By:
- Publication type:
- Article
Inhibition of catechol- O-methyltransferase modifies acute homocysteine rise during repeated levodopa application in patients with Parkinson's disease.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2011, v. 383, n. 6, p. 627, doi. 10.1007/s00210-011-0629-7
- By:
- Publication type:
- Article
Longitudinal evaluation of polyneuropathy in Parkinson's disease.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 9, p. 6136, doi. 10.1007/s00415-024-12579-8
- By:
- Publication type:
- Article
Parkinson's Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 4, p. 954, doi. 10.1007/s00415-019-09657-7
- By:
- Publication type:
- Article
COVID-19 outcomes in hospitalized Parkinson’s disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany.
- Published in:
- Neurological Research & Practice, 2022, v. 4, n. 1, p. 1, doi. 10.1186/s42466-022-00192-x
- By:
- Publication type:
- Article
COVID-19 outcomes in hospitalized Parkinson's disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany.
- Published in:
- Neurological Research & Practice, 2022, v. 4, n. 1, p. 1, doi. 10.1186/s42466-022-00192-x
- By:
- Publication type:
- Article
Pain Perception, Pain Drug Therapy and Health Status in Patients with Parkinson's Disease.
- Published in:
- Neuroepidemiology, 2011, v. 37, n. 3/4, p. 183, doi. 10.1159/000331911
- By:
- Publication type:
- Article
Dynamics of Parkinson's Disease Multimodal Complex Treatment in Germany from 2010–2016: Patient Characteristics, Access to Treatment, and Formation of Regional Centers.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 2, p. 151, doi. 10.3390/cells8020151
- By:
- Publication type:
- Article
Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson's Disease.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 2, p. 105, doi. 10.3390/cells8020105
- By:
- Publication type:
- Article
Impairment of Motor Function Correlates with Neurometabolite and Brain Iron Alterations in Parkinson's Disease.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 2, p. 96, doi. 10.3390/cells8020096
- By:
- Publication type:
- Article
Emerging Immunotherapies for Parkinson Disease.
- Published in:
- Neurology & Therapy, 2019, v. 8, n. 1, p. 29, doi. 10.1007/s40120-018-0122-z
- By:
- Publication type:
- Article
Levodopa increases oxidative stress and repulsive guidance molecule A levels: a pilot study in patients with Parkinson's disease.
- Published in:
- Journal of Neural Transmission, 2016, v. 123, n. 4, p. 401, doi. 10.1007/s00702-016-1519-4
- By:
- Publication type:
- Article
Fewer fluctuations, higher maximum concentration and better motor response of levodopa with catechol- O-methyltransferase inhibition.
- Published in:
- Journal of Neural Transmission, 2014, v. 121, n. 11, p. 1357, doi. 10.1007/s00702-014-1213-3
- By:
- Publication type:
- Article
Levodopa-related cysteinyl-glycine and cysteine reduction with and without catechol- O-methyltransferase inhibition in Parkinson's disease patients.
- Published in:
- Journal of Neural Transmission, 2014, v. 121, n. 6, p. 643, doi. 10.1007/s00702-013-1155-1
- By:
- Publication type:
- Article
Elevation of total homocysteine levels in patients with Parkinson's disease treated with duodenal levodopa/carbidopa gel.
- Published in:
- Journal of Neural Transmission, 2011, v. 118, n. 9, p. 1329, doi. 10.1007/s00702-011-0614-9
- By:
- Publication type:
- Article
Peripheral COMT inhibition prevents levodopa associated homocysteine increase.
- Published in:
- Journal of Neural Transmission, 2009, v. 116, n. 10, p. 1253, doi. 10.1007/s00702-009-0275-0
- By:
- Publication type:
- Article
Cysteinyl-glycine reduction as marker for levodopa-induced oxidative stress in Parkinson's disease patients.
- Published in:
- Movement Disorders, 2011, v. 26, n. 3, p. 543, doi. 10.1002/mds.23384
- By:
- Publication type:
- Article
Exercise improves efficacy of levodopa in patients with Parkinson's disease.
- Published in:
- Movement Disorders, 2007, v. 22, n. 3, p. 427, doi. 10.1002/mds.21346
- By:
- Publication type:
- Article
Inhibition of catechol- O-methyltransferase contributes to more stable levodopa plasma levels.
- Published in:
- Movement Disorders, 2006, v. 21, n. 3, p. 332, doi. 10.1002/mds.20717
- By:
- Publication type:
- Article
Impact of endurance exercise on levodopa-associated cortisol release and force increase in patients with Parkinson’s disease.
- Published in:
- Journal of Neural Transmission, 2008, v. 115, n. 6, p. 851, doi. 10.1007/s00702-008-0018-7
- By:
- Publication type:
- Article